Robyn has a MSc from Stockholm University in Demography and a BA in Economics from New York University. Bringing over 6 years of industry experience in real-world evidence, Robyn has worked on diverse range of research projects across multiple therapeutic areas including autoimmune, cardiometabolic, oncology, and rare diseases. She has conducted epidemiological studies across Europe, leveraging real-world data including Nordic registers and other European data sources. Robyn has experience in strategic guidance, project management, regulatory studies, study design, and scientific writing.